INPLASY202650164

Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes mellitus: protocol for an updated systematic review of evidence from 2006 to May 2026

Keywords: DPP-4 inhibitors; gliptins; sitagliptin; linagliptin; type 2 diabetes; cardiovascular outcomes; bullous pemphigoid; chronic kidney disease; systematic review; ADA guidelines.

Read and download full-text here - PDF 202650164

Review Status: completed but not published